SCHEMBL7208902

SCHEMBL7208902

Fc1cccc(Oc2cccc3cccnc23)c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.54
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
RAB9A P51151 2/20 0.54
NPC1 O15118 1/20 0.54
MAPT P10636 5/20 0.51
LMNA P02545 4/20 0.48
ALDH1A1 P00352 2/20 0.45
HTT P42858 2/20 0.45
GAA P10253 1/20 0.45
MAPK1 P28482 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
GLRA3 O75311 1/20 0.43
MAP4K4 O95819 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL366672 0.83 KDM4E (0.53) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL546185 0.82 RAB9A (0.68) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL7212405 0.81 KDM4E (0.54) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL9446981 0.81 KDM4E (0.54) KDM4EMEN1KMT2ARAB9ANPC1
Hydrochloric Acid SCHEMBL9052059 0.80 RAB9A (0.66) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL6026021 0.80 MEN1 (0.49) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL31592021 0.79 MAP4K4 (0.47) KMT2ARAB9ANPC1MAPTMAP4K4
SCHEMBL4386263 0.79 KDM4E (0.72) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL2094743 0.79 MMP2 (0.45) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL2094739 0.79 MAP4K4 (0.41) KDM4EMEN1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077984-B1 2\"-DEOXY HYGROMYCIN DERIVATIVES PFIZER PROD INC (US) 2003-06-18 EP claimed
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed